You are here: Home » Current Affairs » Coronavirus » News
Business Standard

Fire at Serum Institute building in Pune; vaccine output not hit: Report

SII is manufacturing a vaccine developed by Oxford University and US drugmaker AstraZeneca

Serum Institute of India | Coronavirus Vaccine


fire incident
The incident of fire at the Serum Institute of India took place at Manjari Plant. | Photo: @ANI

A big fire broke out on Thursday inside the sprawling complex of the (SII), the world’s biggest vaccine maker, but a source close to the firm said current production of vaccines was unaffected.

Videos and pictures from Reuters partner ANI showed black smoke billowing out of a grey building in SII’s massive headquarters complex spread over tens of acres in the western city of Pune.

“Thank you everyone for your concern and prayers,” SII CEO Adar Poonawalla said on Twitter.

“So far the most important thing is that there have been no lives lost or major injuries due to the fire, despite a few floors being destroyed.”

SII is producing around 50 million doses of a vaccine developed by Oxford University and AstraZeneca a month at other facilities in the complex.

The fire department said at least five fire trucks had been sent to fight the blaze at the building, which the source described as an “under-construction vaccine plant”.

There was no immediate word on the cause of the fire.

Many low- and middle-income countries are depending on SII delivering vaccines to fight the epidemic.

The AstraZeneca vaccine is already in use in India and has also been shipped to countries such as Bangladesh, Nepal, the Maldives and Bhutan.

The company is also getting ready to produce a vaccine being developed by the U.S. company Novavax Inc.

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Thu, January 21 2021. 16:06 IST